References for:
Strongyloides Hyperinfestation With Pulmonary Hemorrhage and ARDS

[Infect Med 17(3):208-212, 2000. © 2000 Cliggott Publishing, Division of SCP Communications ]

  1. Genta RM. Global prevalence of strongyloidiasis. Rev Infect Dis. 1989;5:755-767.
  2. Cook GA, Rodriguez H, Silva H, et al. Adult respiratory distress secondary to strongyloidiasis. Chest. 1987;92:1115-1116.
  3. Kinjo T, Tsuhako K, Nakazato I, et al. Extensive intra-alveolar hemorrhage caused by disseminated strongyloidiasis. Int J Parasitol. 1998;28: 323-330.
  4. Civantos F, Robinson MJ. Fatal strongyloidiasis following corticosteroid therapy. Am J Dig Dis. 1969;14:643-651.
  5. Thompson JR, Berger R. Fatal adult respiratory distress syndrome following successful treatment of pulmonary strongyloidiasis. Chest. 1991;3:772-774.
  6. Cruz T, Reboucas G, Rocha H. Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med. 1966;275:1093-1096.
  7. Venizelos P, Lopata M, Bardawil WA, Sharp JT. Respiratory failure due to Strongyloides stercoralis in a patient with a renal transplant. Chest. 1980;78:104-106.
  8. Grove DI. Clinical manifestations. In: Grove DI, ed. Strongyloidiasis: A Major Roundworm Infection of Man. Philadelphia: Taylor & Francis; 1989:175-197.
  9. Igra-Siegman Y, Kapila R, Sen P, et al. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis. 1981;3:397-407.
  10. Rivera E, Maldonado N, Velez-Garcia E, et al. Hyperinfection syndrome with Strongyloides stercoralis. Ann Intern Med. 1970;72:199-204.
  11. Boyd WP Jr, Campbell FW, Trudeau WL. Strongyloides stercoralis hyperinfection. Am J Trop Med Hyg. 1978;27:39-41.
  12. Longworth DL, Weller PF. Hyperinfection syndrome with strongyloidiasis. In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases. Vol 7. New York: McGraw Hill; 1986:1-26.
  13. Scowden EB, Schaffner W, Stone WJ. Overwhelming strongyloides: an unappreciated opportunistic infection. Medicine. 1978;57:527-544.
  14. Leighton PM, Macsween HM. Strongyloides stercoralis: the cause of an urticarial-like eruption of 65 years' duration. Arch Intern Med. 1990;150:1747-1748.
  15. Grove DI. Strongyloidiasis: a conundrum for gastroenterologists. Gut. 1994;35:437-440.
  16. Craven JL, Cantrell EG, Lewis MG. Strongyloides stercoralis presenting as necrotizing jejunitis. Trans R Soc Trop Med Hyg. 1971;65:532-533.
  17. Cappello M, Hotez PJ. Disseminated strongyloidiasis. Semin Neurol. 1993;13:169-174.
  18. Wehner JH, Kirsch CM. Pulmonary manifestations of strongyloidiasis. Semin Respir Infect. 1997;12:122-129.
  19. Guerin JM, Leibinger F, Mofredi A. Pulmonary strongyloidiasis. South Med J. 1996;89:741-742.
  20. Bruno P, McAllister K, Matthews JI. Pulmonary strongyloidiasis. South Med J. 1982;75:363-365.
  21. Ford J, Reiss-Levy E, Clark E. Pulmonary strongyloidiasis and lung abscess. Chest. 1981;79: 239-240.
  22. Lin AL, Kessimian N, Benditt JQ. Restrictive pulmonary disease due to interlobular septal fibrosis associated with disseminated infection by Strongyloides stercoralis. Am J Respir Crit Care Med. 1995;151:205-209.
  23. Bradley SL, Dines DE, Brewer NS. Disseminated Strongyloides stercoralis in an immunosuppressed host. Mayo Clinic Proc. 1978;53:332-335.
  24. Purtilo DT, Meyers WM, Connor DH. Fatal strongyloidiasis in immunosuppressed patients. Am J Med. 1974;56:488-493.
  25. Nucci M, Portugal R, Pulcheri W, et al. Strongyloidiasis in patients with hematologic malignancies. Clin Infect Dis. 1995;21:675-677.
  26. Mahmoud AAF. Strongyloidiasis. Clin Infect Dis. 1996;23:949-952.
  27. Smith B, Verghese A, Guiterrez C, et al. Pulmonary strongyloidiasis: diagnosis by sputum gram stain. Am J Med. 1985;79:663-666.
  28. Humpherys K, Hieger LR. Strongyloides stercoralis in routine Papanicolaou-stained sputum smears. Acta Cytol. 1979;23:471-476.
  29. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis. 1989;11:755-767.
  30. Lindo JF, Conway DJ, Atkins NS, et al. Prospective evaluation of enzyme-linked immunosorbent assay and immunoblot methods for the diagnosis of endemic Strongyloides stercoralis infection. Am J Trop Med Hyg. 1994;51:175-179.
  31. Pena Chavvaria A, Swartzelder JC, Villarajos VM, Zeldon R. Mebendazole, an effective broad spectrum antihelminthic. Am J Trop Med Hyg. 1973;22:592-595.
  32. Salazar SA, Berk SH, Howe D, Berk SL. Ivermectin vs thiabendazole in the treatment of strongyloidiasis. Infect Med. 1994;11:50-59.
  33. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg. 1994;88:344-345.
  34. Pitisuttithum P, Supanaranond W, Chindanond D. A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. Southeast Asian J Trop Med Public Health. 1995;26:735-738.
  35. Archibald LK, Beeching NJ, Gill GV, et al. Albendazole is effective treatment for chronic strongyloidiasis. Q J Med. 1993;86:191-195.
  36. Pungpak S, Bunnag D, Chindanond D, Radmoyos B. Albendazole in the treatment of strongyloidiasis. Southeast Asian J Trop Med Public Health. 1987;18:207-210.
  37. Mojon M, Nielsen PB. Treatment of Strongyloides stercoralis with albendazole: a cure rate of 86 per cent. Zentralbl Bakteriol Mikrobiol Hyg [A]. 1987;263:619-624.
  38. Rossignol JF, Maisonneuve H. Albendazole: placebo-controlled study in 870 patients with intestinal helminthiasis. Trans R Soc Trop Med Hyg. 1983;77:707-711.
  39. Pene P, Mojon M, Garin JP, et al. Albendazole: a new broad spectrum anthelmintic. Double-blind multicenter clinical trial. Am J Trop Med Hyg. 1982;31:263-266.
  40. Plourde PJ, Keystone JS. Intestinal nematodiasis. In: Hoeprich PD, Jordan MC, Ronald AR, eds. Infectious Diseases. A Treatise of Infectious Processes. Philadelphia: JD Lippincott Co; 1994: 780-781.
  41. Lucas KG, Brown AE. Strongyloides in the patient with cancer. Infect Med. 1995;4:181-186.